CytoDyn Inc., Author at DrugGenius

News

CytoDyn Files Request With FDA for Priority Review of BLA for First Approval

If granted, the FDA is expected to take action on the Company’s BLA within six months VANCOUVER, Washington, June 01, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or…

View Post

News

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced equity inducement grants to one new employee…

View Post

News

Constellation Pharmaceuticals to Participate in Investor Conference

CAMBRIDGE, Mass., May 29, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that…

View Post

News

Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant

Elucidation of CD68 as a Downstream Target of Adenosine Refines Adenosine Gene Signature into a Practical Pathology Test Provides Opportunity to Further Enrich Patient Selection for Responders Data Includes Additional…

View Post

News

Phathom Pharmaceuticals to Present at Upcoming Investor Conferences

FLORHAM PARK, N.J., May 28, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today…

View Post

News

UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference

SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced…

View Post

News

Geron Corporation Reports First Quarter 2020 Financial Results

MENLO PARK, Calif., May 28, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2020. The Company will host a…

View Post

News

Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities

– Lumos Pharma expects to initiate its Phase 2b LUM-201 trial in Pediatric Growth Hormone Deficiency (PGHD) prior to the end of 2020 – Additional non-dilutive funds expected from anticipated…

View Post

News

MatriSys Bioscience Inc. is pleased to announce that we have been selected as a CONNECT 2020 Cool Company

SAN DIEGO, May 28, 2020 (GLOBE NEWSWIRE) — MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics is pleased to announce that it was named a 2020 “Cool…

View Post

News

Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610

CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host…

View Post